An Update on Choroidal Abnormalities and Retinal Microvascular Changes in Neurofibromatosis Type 1

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2022 Jun 13

PMID 35698197

Authors

Fabiana Mallone

Luca Lucchino

Sandra Giustini

Alessandro Lambiase

Antonietta Moramarco

Affiliations

Soon will be listed here.

Abstract

Neurofibromatosis Type 1 (NF1) is a rare neurocutaneous disorder transmitted in an autosomal dominant fashion, mainly affecting the nervous system, the eye and skin. Ocular diagnostic hallmarks of NF1 include iris Lisch nodules, optic gliomas, orbital and eyelid neurofibromas, eyelid café-au-lait spots. In recent years, a new ocular sign represented by choroidal abnormalities (CAs) has been characterized in NF1. The CAs, identified with near-infrared reflectance, have been reported with a frequency of up to 100% in NF1, and have recently been added to the actual diagnostic criteria for NF1. The present Letter to the journal is intended to provide an update on features and clinical significance of CAs in NF1. Moreover, the relation with other ocular manifestations recently described in NF1 including hyperpigmented spots and retinal microvascular abnormalities is discussed.

Citing Articles

Key features of choroidal abnormalities in neurofibromatosis type 1, a commentary on "Histologic correlates of "choroidal abnormalities" in neurofibromatosis type 1 (NF1)".

Lucchino L, Mallone F, Gharbiya M, Alisi L Acta Neuropathol. 2024; 148(1):22.

PMID: 39150563 DOI: 10.1007/s00401-024-02783-1.

Multimodal Imaging Characteristics and Diagnostic Value of Choroidal Nodules in Patients with Neurofibromatosis Type 1.

Ahmadova N, Kayabasi M, Koksaldi S, Humaz E, Saatci A Turk J Ophthalmol. 2024; 54(3):140-148.

PMID: 38940356 PMC: 11589307. DOI: 10.4274/tjo.galenos.2024.48017.

Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care.

Miyagishima K, Qiao F, Stasheff S, Nadal-Nicolas F Vision (Basel). 2024; 8(2).

PMID: 38804352 PMC: 11130890. DOI: 10.3390/vision8020031.

Multidisciplinary team for patients with neurocutaneous syndromes: The little discussed importance of dentistry.

Tovani-Palone M, Bistagnino F, Shah P Clinics (Sao Paulo). 2024; 79:100332.

PMID: 38364341 PMC: 10881307. DOI: 10.1016/j.clinsp.2024.100332.

Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1.

Mallone F, Alisi L, Lucchino L, Di Martino V, Nebbioso M, Armentano M Int J Mol Sci. 2023; 24(17).

PMID: 37686284 PMC: 10488231. DOI: 10.3390/ijms241713481.

References

Tucci A, Saletti V, Menni F, Cesaretti C, Scuvera G, Esposito S . The absence that makes the difference: choroidal abnormalities in Legius syndrome. J Hum Genet. 2017; 62(11):1001-1004. DOI: 10.1038/jhg.2017.78. View

Nebbioso M, Moramarco A, Lambiase A, Giustini S, Marenco M, Miraglia E . Neurofibromatosis Type 1: Ocular Electrophysiological and Perimetric Anomalies. Eye Brain. 2020; 12:119-127. PMC: 7585783. DOI: 10.2147/EB.S255184. View

Parrozzani R, Frizziero L, Trainiti S, Calciati A, Londei D, Miglionico G . RETINAL VASCULAR ABNORMALITIES RELATED TO NEUROFIBROMATOSIS TYPE 1: Natural History and Classification by Optical Coherence Tomography Angiography in 473 Patients. Retina. 2020; 41(5):979-986. DOI: 10.1097/IAE.0000000000002962. View

Moramarco A, Giustini S, Miraglia E, Sacchetti M . SD-OCT in NIR modality to diagnose retinal microvascular abnormalities in neurofibromatosis type 1. Graefes Arch Clin Exp Ophthalmol. 2018; 256(9):1789-1790. DOI: 10.1007/s00417-018-4028-3. View

Klein R, GLASSMAN L . Neurofibromatosis of the choroid. Am J Ophthalmol. 1985; 99(3):367-8. DOI: 10.1016/0002-9394(85)90376-9. View

Vagge A, Camicione P, Capris C, Sburlati C, Panarello S, Calevo M . Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population. Acta Ophthalmol. 2015; 93(8):e667-71. DOI: 10.1111/aos.12750. View

Kumar V, Singh S . Multimodal imaging of choroidal nodules in neurofibromatosis type-1. Indian J Ophthalmol. 2018; 66(4):586-588. PMC: 5892072. DOI: 10.4103/ijo.IJO_1095_17. View

Wolter J . NERVE FIBRILS IN OVOID BODIES. Arch Ophthalmol. 1965; 73:696-9. DOI: 10.1001/archopht.1965.00970030698019. View

Miraglia E, Moliterni E, Iacovino C, Roberti V, Laghi A, Moramarco A . Cutaneous manifestations in neurofibromatosis type 1. Clin Ter. 2020; 171(5):e371-e377. DOI: 10.7417/CT.2020.2242. View

10.

Kurosawa A, Kurosawa H . Ovoid bodies in choroidal neurofibromatosis. Arch Ophthalmol. 1982; 100(12):1939-41. DOI: 10.1001/archopht.1982.01030040919010. View

11.

Moreno-Morillo F, Fernandez-Vigo J, Burgos-Blasco B, Llorente-la Orden C, Vidal-Villegas B, Santos-Bueso E . Optical coherence tomography angiography of choroidal nodules in neurofibromatosis type-1: A case series. Eur J Ophthalmol. 2021; 32(6):NP91-NP94. PMC: 8935152. DOI: 10.1177/11206721211030781. View

12.

Ueda-Consolvo T, Miyakoshi A, Ozaki H, Houki S, Hayashi A . Near-infrared fundus autofluorescence-visualized melanin in the choroidal abnormalities of neurofibromatosis type 1. Clin Ophthalmol. 2012; 6:1191-4. PMC: 3413334. DOI: 10.2147/OPTH.S35321. View

13.

Abdolrahimzadeh S, Felli L, Piraino D, Mollo R, Calvieri S, Recupero S . Retinal microvascular abnormalities overlying choroidal nodules in neurofibromatosis type 1. BMC Ophthalmol. 2014; 14:146. PMC: 4258815. DOI: 10.1186/1471-2415-14-146. View

14.

Viola F, Villani E, Natacci F, Selicorni A, Melloni G, Vezzola D . Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology. 2011; 119(2):369-75. DOI: 10.1016/j.ophtha.2011.07.046. View

15.

Moramarco A, Lambiase A, Mallone F, Miraglia E, Giustini S . A characteristic type of retinal microvascular abnormalities in a patient with Neurofibromatosis type 1. Clin Ter. 2019; 170(1):e4-e9. DOI: 10.7417/CT.2019.2101. View

16.

Moramarco A, Giustini S, Nofroni I, Mallone F, Miraglia E, Iacovino C . Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1. Graefes Arch Clin Exp Ophthalmol. 2018; 256(2):307-311. DOI: 10.1007/s00417-017-3870-z. View

17.

Vagge A, Corazza P, Desideri L, Camicione P, Agosto G, Vagge R . Ocular biometric parameters changes and choroidal vascular abnormalities in patients with neurofibromatosis type 1 evaluated by OCT-A. PLoS One. 2021; 16(5):e0251098. PMC: 8101920. DOI: 10.1371/journal.pone.0251098. View

18.

Moramarco A, Sacchetti M, Franzone F, Segatto M, Cecchetti D, Miraglia E . Ocular surface involvement in patients with neurofibromatosis type 1 syndrome. Graefes Arch Clin Exp Ophthalmol. 2020; 258(8):1757-1762. DOI: 10.1007/s00417-020-04717-5. View

19.

Pimentel M, Heath A, Wan M, Hussein R, Leahy K, MacDonald H . Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1. Transl Vis Sci Technol. 2022; 11(2):10. PMC: 8819284. DOI: 10.1167/tvst.11.2.10. View

20.

Moramarco A, Miraglia E, Mallone F, Roberti V, Iacovino C, Bruscolini A . Retinal microvascular abnormalities in neurofibromatosis type 1. Br J Ophthalmol. 2019; 103(11):1590-1594. DOI: 10.1136/bjophthalmol-2018-313002. View